BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 35470068)

  • 1. Asporin, an extracellular matrix protein, is a beneficial regulator of cardiac remodeling.
    Huang C; Sharma A; Thakur R; Rai D; Katiki M; Germano JF; Song Y; Singh S; Sin J; Sengstock D; Andres AM; Murali R; Mentzer RM; Gottlieb RA; Piplani H
    Matrix Biol; 2022 Jun; 110():40-59. PubMed ID: 35470068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
    Frangogiannis NG
    Circ Res; 2019 Jun; 125(1):117-146. PubMed ID: 31219741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTRP15 derived from cardiac myocytes attenuates TGFβ1-induced fibrotic response in cardiac fibroblasts.
    Zhao Q; Zhang CL; Xiang RL; Wu LL; Li L
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):591-604. PubMed ID: 32424654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
    Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
    Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress.
    Lerchenmüller C; Rabolli CP; Yeri A; Kitchen R; Salvador AM; Liu LX; Ziegler O; Danielson K; Platt C; Shah R; Damilano F; Kundu P; Riechert E; Katus HA; Saffitz JE; Keshishian H; Carr SA; Bezzerides VJ; Das S; Rosenzweig A
    Circ Res; 2020 Aug; 127(5):631-646. PubMed ID: 32418505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
    Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
    Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asporin Promotes TGF-β-induced Lung Myofibroblast Differentiation by Facilitating Rab11-Dependent Recycling of TβRI.
    Huang S; Lai X; Yang L; Ye F; Huang C; Qiu Y; Lin S; Pu L; Wang Z; Huang W
    Am J Respir Cell Mol Biol; 2022 Feb; 66(2):158-170. PubMed ID: 34705621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis.
    Leerink JM; van de Ruit M; Feijen EAM; Kremer LCM; Mavinkurve-Groothuis AMC; Pinto YM; Creemers EE; Kok WEM
    J Mol Med (Berl); 2021 Sep; 99(9):1195-1207. PubMed ID: 34052857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte peroxisome proliferator-activated receptor α is essential for energy metabolism and extracellular matrix homeostasis during pressure overload-induced cardiac remodeling.
    Wang X; Zhu XX; Jiao SY; Qi D; Yu BQ; Xie GM; Liu Y; Song YT; Xu Q; Xu QB; Gonzalez FJ; Du J; Wang XM; Qu AJ
    Acta Pharmacol Sin; 2022 May; 43(5):1231-1242. PubMed ID: 34376812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.
    Barallobre-Barreiro J; Didangelos A; Schoendube FA; Drozdov I; Yin X; Fernández-Caggiano M; Willeit P; Puntmann VO; Aldama-López G; Shah AM; Doménech N; Mayr M
    Circulation; 2012 Feb; 125(6):789-802. PubMed ID: 22261194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload.
    Wang X; Li W; Yue Q; Du W; Li Y; Liu F; Yang L; Xu L; Zhao R; Hu J
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
    Perestrelo AR; Silva AC; Oliver-De La Cruz J; Martino F; Horváth V; Caluori G; Polanský O; Vinarský V; Azzato G; de Marco G; Žampachová V; Skládal P; Pagliari S; Rainer A; Pinto-do-Ó P; Caravella A; Koci K; Nascimento DS; Forte G
    Circ Res; 2021 Jan; 128(1):24-38. PubMed ID: 33106094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
    Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
    Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.
    Kazakov A; Hall RA; Werner C; Meier T; Trouvain A; Rodionycheva S; Nickel A; Lammert F; Maack C; Böhm M; Laufs U
    Basic Res Cardiol; 2018 Sep; 113(6):42. PubMed ID: 30191336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASPORIN: A root of the matter in tumors and their host environment.
    Lall SP; Alsafwani ZW; Batra SK; Seshacharyulu P
    Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189029. PubMed ID: 38008263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
    Wang HB; Yang J; Shuai W; Yang J; Liu LB; Xu M; Tang QZ
    J Am Heart Assoc; 2020 Sep; 9(17):e015307. PubMed ID: 32856514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.